Pharma Pulse: FDA Advances New Approval Pathway, as Obesity Care and Metabolic Treatments Gain Momentum

Pharma Pulse: FDA Advances New Approval Pathway, as Obesity Care and Metabolic Treatments Gain Momentum

This episode of Pharma Pulse discusses how the FDA’s new plausible mechanism pathway, WeightWatchers’ plans to offer oral Wegovy, and emerging evidence on berberine are shaping the future of obesity and metabolic health care.

A Milestone Week for Obesity Care

By Joe Nadglowski, President and Chief Executive Officer Reflections on a Big Week for Obesity Care The first week of November was quite the whirlwind for the OAC team! We knew it was going to be a busy one, with half of our staff, myself included, in Atlanta for ObesityWeek, The Obesity Society’s annual meeting. Throughout the week, we had more than two dozen partner meetings, presented multiple posters highlighting our lived experience researc…